Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Optomed

2.61 EUR

+2.76 %

5,647 following
Corporate customer

OPTOMED

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Optomed

Q1/25Q2/25Q3/25Q4/252025Q1/26eQ2/26eQ3/26eQ4/26e
Revenue4.03.84.44.817.14.04.44.55.2
EBITDA-0.7-0.9-0.5-1.3-3.5-0.5-0.30.10.1
EBIT (adj.)-1.3-1.5-1.2-2.0-6.0-1.2-1.0-0.6-0.6
EBIT-1.3-1.5-1.2-2.0-6.0-1.2-1.0-0.6-0.6
EBIT-% (adj.)-33.3 %-40.1 %-26.5 %-41.3 %-35.3 %-29.9 %-21.9 %-14.0 %-11.2 %
EBIT-%-33.3 %-40.1 %-26.5 %-41.3 %-35.3 %-29.9 %-21.9 %-14.0 %-11.2 %
Profit before taxes-1.6-1.7-1.6-1.9-6.7-1.2-1.0-0.7-0.6
Net income-1.6-1.6-1.5-1.9-6.6-1.2-1.0-0.7-0.6
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.